USPTO Examiner WEBB WALTER E - Art Unit 1612

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19307939COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACIDAugust 2025October 2025Allow200NoNo
19177144Lip Balm Containing Caffeine, Nicotine or TestosteroneApril 2025December 2025Abandon820YesNo
19029372Orally Adhering Lozenges Containing Soluble Dietary FiberJanuary 2025October 2025Abandon911NoNo
18978002GUM-PROTECTING AND TEETH-WHITENING STRIP AND PREPARATION METHOD THEREOFDecember 2024May 2025Allow520NoNo
18951096Lip Balm Containing Caffeine, Nicotine or TestosteroneNovember 2024March 2025Allow410NoNo
18842405ORAL CARE PRODUCTAugust 2024February 2025Allow500NoNo
18781300LIP BALM CONTAINING CAFFEINE, NICOTINE OR TESTOSTERONEJuly 2024August 2024Allow100NoNo
18781282LIP BALM CONTAINING CAFFEINE, NICOTINE OR TESTOSTERONEJuly 2024August 2024Allow100NoNo
18757012HYPERTONIC ANTIMICROBIAL THERAPEUTIC COMPOSITIONSJune 2024August 2025Allow1310NoNo
18733977SINGLE DOSE ORAL HYGIENE UNIT OF TOOTHPASTE COMPOSITION AND METHOD OF MANUFACTUREJune 2024September 2025Abandon1521NoNo
18712146SKIN MIMICRY COMPOSITIONS AND IMPLANTSMay 2024March 2026Allow2200NoNo
18699754TOOTHPASTE UTILIZING ROCHELLE SALT (SEGNETTE SALT) AS ABRASIVEApril 2024February 2026Allow2200NoNo
18614050Core Shell Silica Particles and Use for Malodor ReductionMarch 2024March 2025Allow1210NoNo
18602863ORAL HYGIENE COMPOSITIONS AND METHODS OF USEMarch 2024March 2025Allow1210NoNo
18586163ORAL HYGIENE COMPOSITIONS AND METHODS OF USEFebruary 2024August 2024Allow510YesNo
18418609Oral Care Compositions Comprising Hops Beta Acid And Amino AcidJanuary 2024February 2026Allow2540YesNo
18404339ORAL CARE ARTICLE COMPRISING A HYDROPHOBIC DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING A BLEACHING AGENTJanuary 2024December 2024Allow1110NoNo
18545611COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULIDecember 2023August 2025Abandon2020NoNo
18534641Method And Apparatus For Preventing Plaque, Calculus, And Hard Deposits In Body Cavities And The MouthDecember 2023August 2025Abandon2020NoNo
18525147WATER SOLUBLE COMPOSITION AND PRODUCTION METHOD THEREOFNovember 2023January 2024Allow200NoNo
18495090ORAL CARE ARTICLE COMPRISING A DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING A BLEACHING AGENTOctober 2023August 2024Allow1010NoNo
18495174ORAL CARE ARTICLE COMPRISING A DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING A BLEACHING AGENTOctober 2023August 2024Allow1010NoNo
18495126ORAL CARE ARTICLE COMPRISING A HYDROPHOBIC DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING AN ACTIVE AGENTOctober 2023August 2024Allow1010NoNo
18372408STEVIA BLENDS CONTAINING REBAUDIOSIDE BSeptember 2023March 2026Allow2910NoNo
18235118ORAL CARE CLEANING TABLETAugust 2023August 2025Allow2400NoNo
18273001COMPOSITION FOR USE IN DEGRADATION OF BIOFILM OR PREVENTION OF BIOFILM FORMATIONJuly 2023February 2026Abandon3110NoNo
18272521PHOTOCURABLE RESIN COMPOSITION FOR NAILS OR ARTIFICIAL NAILS, CURED PRODUCT, AND METHOD FOR COATING NAILS OR ARTIFICIAL NAILSJuly 2023November 2025Allow2800NoNo
18217568WOUND CLEANSING METHODJuly 2023June 2024Allow1210YesNo
18214964COMPOSITIONS AND METHODS FOR DENTAL MINERALIZATIONJune 2023June 2024Allow1210NoNo
18326273ORAL CARE WHITENING COMPOSITIONSMay 2023September 2025Abandon2830NoNo
18318459TOOTH BRIGHTENING COMPOSITION, KIT, AND METHOD OF USING THE SAMEMay 2023August 2025Allow2700NoNo
18304877PHOSPHATE CROSSLINKED STARCH NANOPARTICLE AND DENTAL TREATMENTSApril 2023August 2025Allow2720NoYes
18133529WHITENING TOOTHPASTE CAPABLE OF EFFECTIVELY REMOVING DENTAL PLAQUE AND TARTARApril 2023July 2023Allow300NoNo
18029864TOPICAL COMPOSITION FOR NANOBUBBLE COSMETICMarch 2023August 2024Allow1621NoNo
18191219OSIMERTINIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCERMarch 2023January 2024Abandon1010NoNo
18169367Core Shell Silica Particles and Use for Malodor ReductionFebruary 2023November 2023Allow910NoNo
18161529Dentifrice composition comprising non-crustacean derived chitosanJanuary 2023February 2025Abandon2520NoYes
18101047Nasal Hygiene Method and FormulationJanuary 2023March 2025Abandon2630YesNo
18159019DENTAL MATERIAL COMPOSITIONS FOR CLEANSING AND REMOVAL OF ANIONIC CONTAMINANTS FROM SUBSTRATES & THEIR METHODS OF USEJanuary 2023June 2025Allow2900NoNo
18098033METHOD FOR PROVIDING A BEVERAGE ADDITIVEJanuary 2023April 2025Allow2700NoNo
18150712ENZYME BASED COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULIJanuary 2023July 2025Allow3110YesNo
18084879Toothpaste CompositionDecember 2022May 2025Abandon2840YesNo
18082737COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITINGDecember 2022March 2024Allow1520NoNo
18002033THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR LIGHTENING PRODUCTDecember 2022October 2025Allow3510NoNo
18066730SOLUBLE FIBER LOZENGEDecember 2022June 2024Allow1830NoNo
18063706Adhesive patch to oral cavity having improved stability and usabilityDecember 2022July 2025Allow3210NoNo
18049670PROBES FOR IMAGING B-AMYLOID AND INHIBITION OF B-AMYLOID AGGREGATIONOctober 2022August 2025Allow3301NoNo
18046312MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXAMETHASONEOctober 2022December 2024Allow2730NoYes
18046416BUPIVACAINE MULTIVESICULAR LIPOSOME FORMULATIONS AND USES THEREOFOctober 2022December 2024Allow2730NoYes
17962748Thermally Gelling Drug FormulationsOctober 2022August 2023Abandon1021NoNo
17938858HYDROXYAPATITE-SUPPORTING POROUS SILICA PARTICLES, METHOD FOR PRODUCING HYDROXYAPATITE-SUPPORTING POROUS SILICA PARTICLES, AND COMPOSITION COMPRISING HYDROXYAPATITE-SUPPORTING POROUS SILICA PARTICLESOctober 2022September 2025Allow3510NoNo
17916507VIRAL INFECTIONS - TREATMENT WITH CONVALESCENT PLASMA/SERUMSeptember 2022March 2026Allow4121YesNo
17915377IMMUNOTHERANOSTIC AGENT TARGETING MESENCHYMAL STEM CELL-DERIVED CANCER CELLS AND MESENCHYMAL STEM CELL ASSOCIATED DISEASESeptember 2022September 2025Allow3601NoNo
17915453PROCESS FOR PRODUCTION OF VITAMIN ASeptember 2022May 2025Allow3100NoNo
17913268AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENTSeptember 2022November 2025Abandon3801NoNo
17905011TUNABLE EXTENDED RELEASE HYDROGELSAugust 2022November 2025Abandon3901NoNo
17888242COMPOSITIONS, PRODUCTS, SYSTEM, AND METHOD FOR PERMING HAIRAugust 2022January 2024Allow1711NoNo
17887237Oral Care CompositionsAugust 2022August 2023Abandon1220NoNo
17869261Method for Producing Pet Dental TreatJuly 2022May 2024Allow2200NoNo
17867424Bleaching GelJuly 2022September 2025Abandon3830NoYes
17811035ORAL CARE COMPOSITIONSJuly 2022December 2023Allow1720NoNo
17853862Zinc - Amino Acid - Lauryl Sulfate Complex with Antimicrobial ActivityJune 2022October 2023Allow1611NoNo
17853788Oral Care CompositionsJune 2022June 2023Allow1110NoNo
17789430AQUEOUS ZINC ORAL CARE COMPOSITIONS WITH FLUORIDEJune 2022October 2025Allow4020NoNo
17847852NANO-EMULSION COMPOSITION FOR TOOTH WHITENING AND METHOD FOR PRODUCING THE SAMEJune 2022September 2024Allow2740NoNo
17807399ANTISEPTIC AND/OR ANTI-INFLAMMATORY GEL FOR TREATMENT OF ORAL CAVITY DISEASES COMPRISING POLYVINYL ALCOHOL AND POLYACIDSJune 2022August 2024Abandon2630NoNo
17785203ASSEMBLY AND METHOD FOR THE PREPARATION OF A WOUND DRESSINGJune 2022May 2025Allow3601NoNo
17757161A MATERIAL FOR THE MANUFACTURING OF OPHTHALMIC IMPLANTS BY PHOTO-POLYMERIZATION METHODJune 2022February 2025Allow3200NoNo
17832556COMPOSITIONS AND METHODS FOR DENTAL MINERALIZATIONJune 2022March 2023Allow1010NoNo
17831150Orally Adhering Lozenges Containing Soluble Dietary FiberJune 2022October 2024Allow2940NoYes
17828179Oral Care Composition Comprising RottlerinMay 2022May 2024Abandon2320NoYes
17825372Oral Care CompositionsMay 2022February 2026Abandon4540NoYes
17752533Oral Care CompositionsMay 2022February 2026Abandon4530NoYes
17746817ORAL HYGIENE COMPOSITIONS AND METHODS OF USEMay 2022January 2024Allow2021NoNo
17661153LIPOSOME COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF AND USE THEREOF IN THERAPYApril 2022June 2025Allow3740YesNo
17717391Process For Making An Oral Care Article Of ManufactureApril 2022December 2023Allow2120NoNo
17766973Oral Care Compositions and Methods of UseApril 2022January 2026Abandon4620NoNo
17707822ORAL CARE COMPOSITIONMarch 2022August 2025Allow4030NoNo
17656307Oral Care CompositionsMarch 2022November 2023Abandon1911NoNo
17694044Oral Care Compositions and Methods of Using the CompositionsMarch 2022June 2025Abandon3920NoYes
17642565SYSTEM FOR CORNEAL CROSS-LINKING AND CORRECTING VISION BY USING LED CONTACT LENS AND EYE DYEMarch 2022May 2025Allow3800NoNo
17753446COMPOSITIONS COMPRISING DISSUBSTITUTE TEREPHTHALATES AND ALSO LIGHT PROECTION FILTER SUBSTANCES, DEODORANT AND/OR ANTIPERSPIRANT ACTIVE INGREDIENTSMarch 2022October 2025Abandon4301NoNo
17652948Oral Care Whitening CompositionsMarch 2022February 2023Allow1210NoNo
17652496Antiperspirant that Reduces/Eliminates Yellowing on ClothingFebruary 2022October 2024Abandon3141YesNo
17675285Peroxymonosulfate Whitening StripsFebruary 2022September 2024Allow3140NoNo
17668840Dental Medicament ApplicatorFebruary 2022May 2022Allow300NoNo
17629177NANO-MICELLE PREPARATION OF ICARITIN AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFJanuary 2022August 2025Abandon4320NoNo
17577672Oral Care CompositionsJanuary 2022December 2025Abandon4640NoYes
17568709DITHIONITE SHELF-STABLE SWEETENERSJanuary 2022February 2024Abandon2520NoNo
17620089PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND ETHOXYLATED FATTY ALCOHOLDecember 2021June 2025Abandon4220NoNo
17618664WATER-IN-OIL EMULSION COMPOSITIONDecember 2021June 2024Allow3000NoNo
17596275MOULDABLE ARTIFICIAL BONE COMPOSITE MATERIAL AND PREPARATION METHOD THEREOFDecember 2021October 2025Allow4711YesNo
17542370MANUFACTURE OF FREEZE-DRIED COSMETICDecember 2021September 2023Abandon2220NoNo
17539273ELECTROSPUN DEXTRAN FIBERS AND DEVICES FORMED THEREFROMDecember 2021August 2024Allow3321NoNo
17538201STABLE COMPOSITIONS OF UNCOMPLEXED IODINE AND METHODS OF USENovember 2021January 2023Allow1410NoNo
17614629STABLE GEL COMPOSITION HAVING HIGH OIL CONTENT, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFNovember 2021November 2025Allow4821YesNo
17529319Making An Oral Care Article Of ManufactureNovember 2021April 2023Abandon1710NoNo
17611862PHARMACEUTICAL COMPOSITION FOR JOINT DISEASE TREATMENT AND METHOD FOR PRODUCING SAMENovember 2021May 2025Abandon4201NoNo
17610356IMMUNE-STIMULATING COMPOSITIONS FOR AQUACULTURE SPECIESNovember 2021April 2025Abandon4101NoNo
17519931Oral Care Whitening CompositionsNovember 2021January 2022Allow300NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WEBB, WALTER E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
118
Examiner Affirmed
94
(79.7%)
Examiner Reversed
24
(20.3%)
Reversal Percentile
33.8%
Lower than average

What This Means

With a 20.3% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
251
Allowed After Appeal Filing
49
(19.5%)
Not Allowed After Appeal Filing
202
(80.5%)
Filing Benefit Percentile
24.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 19.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner WEBB, WALTER E - Prosecution Strategy Guide

Executive Summary

Examiner WEBB, WALTER E works in Art Unit 1612 and has examined 1,097 patent applications in our dataset. With an allowance rate of 47.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.

Allowance Patterns

Examiner WEBB, WALTER E's allowance rate of 47.9% places them in the 11% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by WEBB, WALTER E receive 2.43 office actions before reaching final disposition. This places the examiner in the 70% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by WEBB, WALTER E is 33 months. This places the examiner in the 45% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +14.1% benefit to allowance rate for applications examined by WEBB, WALTER E. This interview benefit is in the 52% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.4% of applications are subsequently allowed. This success rate is in the 12% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 19.2% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 30.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 32% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 41.3% of appeals filed. This is in the 8% percentile among all examiners. Of these withdrawals, 43.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 73.0% are granted (fully or in part). This grant rate is in the 79% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.6% of allowed cases (in the 72% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.